KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $290.9 million.

  • Charles River Laboratories International's Other Non-Current Assets fell 524.81% to $290.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $290.9 million, marking a year-over-year decrease of 524.81%. This contributed to the annual value of $278.2 million for FY2024, which is 1006.84% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Other Non-Current Assets stood at $290.9 million, which was down 524.81% from $296.5 million recorded in Q2 2025.
  • Charles River Laboratories International's Other Non-Current Assets' 5-year high stood at $435.6 million during Q2 2022, with a 5-year trough of $148.3 million in Q4 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $301.2 million (2024), whereas its average is $285.0 million.
  • Within the past 5 years, the most significant YoY rise in Charles River Laboratories International's Other Non-Current Assets was 10864.92% (2023), while the steepest drop was 6431.3% (2023).
  • Charles River Laboratories International's Other Non-Current Assets (Quarter) stood at $151.5 million in 2021, then fell by 2.15% to $148.3 million in 2022, then surged by 108.65% to $309.4 million in 2023, then dropped by 10.07% to $278.2 million in 2024, then grew by 4.55% to $290.9 million in 2025.
  • Its Other Non-Current Assets stands at $290.9 million for Q3 2025, versus $296.5 million for Q2 2025 and $294.1 million for Q1 2025.